Literature DB >> 8339208

Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group.

M B Menke-Pluymers1, W C Hop, J Dees, M van Blankenstein, H W Tilanus.   

Abstract

BACKGROUND: To evaluate the importance of the length of columnar-lined esophagus, sex, age, smoking, and drinking habits as risk factors for malignant degeneration, the authors performed a retrospective case-control study comparing patients with and without adenocarcinoma in Barrett esophagus.
METHODS: The records of 96 patients (53 male and 43 female; mean age, 61 years) with a benign columnar-lined esophagus and 62 patients (47 male and 15 female; mean age, 62 years) with an adenocarcinoma in columnar-lined esophagus referred to the Rotterdam Esophageal Tumor Study Group, diagnosed over the same period (1978-1985), were reviewed. A frequency distribution of the length of columnar-lined esophagus in both groups was made. Statistical analysis was performed with multivariate methods.
RESULTS: The length of columnar-lined esophagus was related significantly to carcinoma: a doubling of the length resulted in a 1.7 times increased risk. Smokers had a 2.3-fold increased risk as compared with nonsmokers. Male sex as a risk factor approached statistical significance (P = 0.06). Adjusted for these risk factors, no relation between carcinoma and age or alcohol consumption was found.
CONCLUSIONS: The risk of development of an adenocarcinoma in Barrett esophagus increased with the length of Barrett epithelium. Smoking and possibly male sex were also risk factors. The identification of these risk factors may help in developing more efficient screening programs for patients with Barrett esophagus.

Entities:  

Mesh:

Year:  1993        PMID: 8339208     DOI: 10.1002/1097-0142(19930815)72:4<1155::aid-cncr2820720404>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  Proton pump inhibitors for Barrett's oesophagus.

Authors:  G Triadafilopoulos
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 2.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

3.  Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia.

Authors:  S J Hughes; M A Morse; C M Weghorst; H Kim; P B Watkins; F P Guengerich; M B Orringer; D G Beer
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

4.  Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

Authors:  H Tigges; K H Fuchs; J Maroske; M Fein; S M Freys; J Müller; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

5.  Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?

Authors:  Evanthia Zampeli; George Karamanolis; George Morfopoulos; Elias Xirouchakis; Vasiliki Kalampoki; Spyros Michopoulos; Sotiria Savva; Vasilios Tzias; Irene Zouboulis-Vafiadis; Dimitrios Kamberoglou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 6.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

7.  Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria.

Authors:  T Akiyama; M Inamori; K Akimoto; H Iida; H Mawatari; H Endo; T Ikeda; Y Nozaki; K Yoneda; Y Sakamoto; K Fujita; M Yoneda; H Takahashi; S Hirokawa; A Goto; Y Abe; H Kirikoshi; N Kobayashi; K Kubota; S Saito; A Nakajima
Journal:  Dig Dis Sci       Date:  2008-11-12       Impact factor: 3.199

8.  The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.

Authors:  T J Hayeck; C Y Kong; S J Spechler; G S Gazelle; C Hur
Journal:  Dis Esophagus       Date:  2010-03-26       Impact factor: 3.429

9.  Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis.

Authors:  Tomoyuki Akiyama; Masahiko Inamori; Hiroshi Iida; Hiroki Endo; Kunihiro Hosono; Yasunari Sakamoto; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Tomoko Koide; Chikako Tokoro; Ayumu Goto; Yasunobu Abe; Takeshi Shimamura; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

10.  Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.

Authors:  Chin Hur; Tristan J Hayeck; Jennifer M Yeh; Ethan M Richards; Ethan B Richards; Stuart J Spechler; G Scott Gazelle; Chung Yin Kong
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.